Good MorningThe equity market continues to drift sideways near the recently set all-time high while traders wait on the next cues for the market. The Dow Jones Industrial Average closed with a small loss while the NASDAQ Composite and S&P 500 both eeked out small gains. On the one hand, traders are hopeful another round of stimulus will juice an already strong economic rebound while on the other the risks of COVID continue to weigh on the economy.
The newest round of stimulus is expected to be signed into law by mid-March and will include another check for most Americans. One of the final sticking points to be decided is who, exactly will get another check. Also to be included in the bill is an increase to the minimum wage and an extension of unemployment benefits.
Featured: Trump Just Gave the Green Light to Rewrite Social Security? (Ad) 
|
Politics | | | World shares were mostly lower Friday after Wall Street wobbled to a nearly flat finish, though the S&P 500 and the Nasdaq composite still logged record highs.
Most Asian markets were closed to mark the Lunar New Year.
Investors are hoping for a new round of U.S. g... Read the Full Story |
|
From Our Partners2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. | | | 👉[Click here to access your FREE AI stocks report now.] |
|
Stocks | | |
With so many people focused on renewable energy companies these days, oil & gas stocks have largely become an afterthought for investors. While it’s safe to say that the rise of clean energy is a long-term trend worth buying into, that doesn’t mean that oil & gas companies can&... Read the Full Story |
|
Markets | | | Tier 1 automotive parts supplier American Axle and Manufacturing Holdings (NYSE: AXL) stock is slowly recovering back towards pre-COVID 19 levels. Shares underperformed the benchmark S&P 500 index (NYSEARCA: SPY)mostly from resonating effects of the pandemic. Read the Full Story |
|
|
Markets | | | Putting 2021 under the microscope, there are some particularly compelling stocks that look like they can double by the end of the year if not sooner. These health care companies have the near-term catalysts and support from sell-side analysts Read the Full Story |
|
Politics | | | BERLIN — German pharmaceutical company CureVac says it has begun submitting data on its coronavirus vaccine to the EU regulator with the aim of speeding up the approval process.
The Amsterdam-based European Medicines Agency confirmed Friday that it has begun a review of the vaccine an... Read the Full Story |
|
|
Tech | | | Australia’s Parliament will debate making Google and Facebook pay for news after a Senate committee on Friday recommended no changes to drafts of the world’s first such laws.
The Senate Economics Legislation Committee has been scrutinizing the bill since it was introduced in Parliame... Read the Full Story |
|
Politics | | | MELBOURNE, Australia — Australia’s second-largest city will begin its third lockdown due to a rapidly spreading COVID-19 cluster centered on hotel quarantine.
The five-day lockdown will be enforced across Victoria state to prevent the virus spreading from the state capital Melbourne,... Read the Full Story |
|
Tech | | | MELBOURNE, Australia — Australia is on track to manufacture and administer its own version of the AstraZeneca COVID-19 vaccine by the end of March, the health minister said on Friday.
Health Minister Greg Hunt was speaking at biotechnology company CSL Ltd.’s plant in Melbourne where t... Read the Full Story |
|
Markets | | | Cannabis Stocks: Follow The Money But Don’t Chase Prices
With the cannabis market back in the spotlight we thought it might be a good idea to highlight some of the lesser-known and perhaps underloved names in the sector. Who knows, maybe we’ll turn up a great investment but in the meant... Read the Full Story |
|
Markets | | | Steel producer United States Steel Corporation (NYSE: X) stock has seen a strong surge in 2021 followed by a sharp decline but still performing well against the benchmark S&P 500 index (NYSEARCA: SPY). Read the Full Story |
|
The Early Bird Stock Of The Day Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company's lead compounds, reproxalap and ADX-629, target reactive aldehyde species (RASP), which are elevated in ocular and systemic inflammatory disease, leading to elevated levels of cytokine release via activation of a broad array of inflammatory factors, including NF-κB, inflammasomes, and Scavenger Receptor A. Reproxalap is being evaluated in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. The company's clinical pipeline also includes ADX-2191, a dihydrofolate reductase inhibitor in Phase 3 testing for proliferative vitreoretinopathy, and ADX-1612, a chaperome inhibitor in Phase 2 testing for COVID-19 and ovarian cancer. | | View Today's Stock Pick |
|
